STREAMER : STent Restenosis And MEdicaments Release
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
It is a pilot study to evaluate the feasibility and the efficiency of local delivery of
paclitaxel after stenting of long femoropopliteal arterial lesions TASC C and D before the
realization of a large randomized multicentric study. Patients concerned are in critical
ischemia.